Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody

被引：143
|
作者：
van der Ent, Cornelis K.
Hoekstra, Hans
Rijkers, Ger T.
机构：
[1] Univ Utrecht, Ctr Med, Dept Pediat Resp Dis, NL-3508 AB Utrecht, Netherlands
[2] Hieronyms Bosch Hosp, Dept Pediat, sHertogenbosch, Netherlands
[3] Univ Utrecht, Ctr Med, Dept Pediat Immunol, Utrecht, Netherlands
来源：
THORAX | 2007年 / 62卷 / 03期
关键词：
D O I：
10.1136/thx.2004.035519
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Allergic bronchopulmonary aspergillosis (ABPA) can cause severe worsening of the respiratory condition in patients with cystic fibrosis. Treatment can result in steroid dependency and serious adverse events. A dramatic and rapid improvement of respiratory symptoms and lung function after a single dose of anti-IgE antibody (omalizumab) in a 12-year-old girl with cystic fibrosis and ABPA is described. This is the first report of this experimental treatment. It suggests an important role for IgE in the pathogenesis of ABPA and offers new therapeutic possibilities.
引用
收藏
页码：276 / 277
页数：2
相关论文
共 50 条
  • [1] Treatment of Allergic Bronchopulmonary Aspergillosis (ABPA) in CF With Anti-IgE Antibody (Omalizumab)
    Kanu, Adaobi
    Patel, Kalpana
    [J]. PEDIATRIC PULMONOLOGY, 2008, 43 (12) : 1249 - 1251
  • [2] Anti-IgE therapy for allergic bronchopulmonary aspergillosis
    Homma, Tetsuya
    Kurokawa, Masatsugu
    Matsukura, Satoshi
    Yamaguchi, Munehiro
    Adachi, Mitsuru
    [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2016, 49 (03) : 459 - 463
  • [3] Treatment of allergic bronchopulmonary aspergillosis with anti-IgE antibody (omalizumab) in an asthmatic adult - A case report
    Zink, A.
    Ott, S. R.
    Geiser, T.
    [J]. SWISS MEDICAL WEEKLY, 2009, 139 (13-14) : 14S - 14S
  • [4] Anti-IgE Monoclonal Antibody in Allergic Bronchopulmonary Aspergillosis Not Responding to Systemic Steroids
    Sharma, Pratibha
    Ganga, Ranganath T.
    [J]. JOURNAL OF HEALTH AND ALLIED SCIENCES NU, 2021, 11 (03): : 204 - 206
  • [5] Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis
    Jat, Kana R.
    Walia, Dinesh K.
    Khairwa, Anju
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (09):
  • [6] Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis
    Jat, Kana R.
    Walia, Dinesh K.
    Khairwa, Anju
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (11):
  • [7] Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis
    Jat, Kana R.
    Walia, Dinesh K.
    Khairwa, Anju
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (03):
  • [8] Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis
    Jat, Kana R.
    Walia, Dinesh K.
    Khairwa, Anju
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (09):
  • [9] Anti IgE antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis
    Zicari, A. M.
    Celani, C.
    De Castro, G.
    De Biase, R. Valerio
    Duse, M.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (13) : 1839 - 1841
  • [10] Steroid sparing effect of anti-IgE antibody in allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis
    Amaddeo, Alessandro
    Bramuzzo, Matteo
    Saletta, Susanna
    Poli, Furio
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
12345